Dr Reddys Laboratories

Market Cap

1,00,988.70 Cr

EPS

335.22

PE Ratio

18.34

Dividend Yield

0.68 %

Industry

Healthcare

52 Week High

1,421.49

52 Week Low

1,092.45

PB Ratio

3.20

Debt to Equity

0.06

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from34 analysts

Analysts have suggested that investors can buy this stock

Buy+41.18 %

+41.18 %

Hold+23.53 %

+23.53 %

Sell+35.29 %

+35.29 %

Company News

View All News

Dr. Reddy's Laboratories Completes Sale of Louisiana Subsidiary3 days ago

Dr. Reddy's Laboratories has announced the completion of the sale of its subsidiary, Dr. Reddy's Laboratories Louisiana LLC. This move represents a significant corporate action for the pharmaceutical company, potentially impacting its operational structure and financial position in the United States market.

Dr. Reddy's Laboratories to Consider Q4 Results on May 94 days ago

Dr. Reddy's Laboratories has announced that it will consider its fourth quarter financial results on May 9. This indicates that the company is preparing to release its earnings report for the last quarter of the fiscal year.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,764.75	4,28,233.30	35.92	49,887.20	12.06	9,648	13.77	61.58
Divis Laboratories	5,840.65	1,56,910.50	74.97	8,184.00	0.89	1,600	64.53	55.23
Cipla	1,511.20	1,23,084.40	24.45	26,520.70	14.17	4,155	47.38	60.28
Torrent Pharmaceuticals	3,245.05	1,10,720.70	58.75	10,785.70	11.59	1,656	13.54	61.68
Dr Reddys Laboratories	1,177.90	1,00,988.70	18.34	28,905.40	12.36	5,578	1.69	51.86
Mankind Pharma	2,398.05	97,867.10	48.47	10,615.60	19.57	1,942	-16.38	56.07
Lupin	2,068.75	96,711.60	32.93	20,141.50	19.94	1,936	38.82	54.50
Zydus Life Science	907.35	92,945.80	20.14	19,831.50	13.82	3,831	29.92	48.54
Aurobindo Pharma	1,194.95	70,253.80	19.68	29,559.20	17.55	3,169	-10.04	61.05
Abbott	31,101.85	66,026.50	49.49	6,097.20	10.80	1,201	16.01	61.04

Growth Rate

Revenue Growth

12.36 %

Net Income Growth

23.75 %

Cash Flow Change

-22.83 %

ROE

1.96 %

ROCE

-3.56 %

EBITDA Margin (Avg.)

6.12 %

Quarterly Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	3,887	3,813	4,061	4,030	3,841	3,302	3,630	3,747	3,575	3,354	3,578	3,849	3,580	3,779	3,937	3,961	4,116	4,290	4,867	4,469	4,516	4,512	4,955	5,015	4,829	5,044	5,993	5,394	5,569	6,079	6,361	6,835	6,443	6,917	7,199	7,434	7,284	7,866	8,330	8,513
Expenses	3,271	2,765	2,888	2,996	3,313	2,855	2,989	2,859	3,021	3,010	2,890	3,041	2,990	2,968	3,058	3,060	3,211	3,117	3,749	4,686	3,500	3,305	3,755	4,403	3,715	4,211	4,427	4,123	5,024	4,292	4,433	4,851	4,781	4,696	4,894	5,214	5,283	5,566	5,962	6,108
EBITDA	616	1,048	1,173	1,034	528	447	640	888	553	344	687	808	590	812	879	901	905	1,174	1,118	-217	1,016	1,207	1,200	613	1,114	833	1,566	1,271	545	1,787	1,928	1,983	1,662	2,221	2,305	2,220	2,001	2,300	2,368	2,405
Operating Profit %	15 %	26 %	28 %	25 %	12 %	12 %	17 %	23 %	15 %	9 %	18 %	20 %	15 %	20 %	19 %	21 %	20 %	19 %	22 %	-7 %	21 %	25 %	23 %	11 %	21 %	14 %	23 %	23 %	8 %	18 %	30 %	28 %	24 %	30 %	29 %	28 %	25 %	27 %	26 %	27 %
Depreciation	0	203	224	235	277	244	262	267	254	259	270	272	276	279	279	290	287	289	313	287	274	292	317	311	309	284	294	294	293	302	309	324	316	353	376	374	368	381	397	471
Interest	23	28	22	16	17	15	13	16	20	22	22	17	18	20	21	24	25	30	30	15	23	23	25	19	30	19	23	22	32	35	31	42	35	37	35	39	59	60	76	82
Profit Before Tax	593	831	960	733	273	199	396	622	337	81	409	547	314	529	599	601	606	869	786	-506	736	901	873	295	815	556	1,273	974	259	1,468	1,614	1,638	1,329	1,850	1,917	1,829	1,605	1,883	1,917	1,874
Tax	74	184	185	147	150	45	87	130	-1	14	103	244	42	53	81	101	151	193	-321	33	-45	306	101	267	258	175	277	265	162	279	499	394	369	445	435	448	295	490	576	470
Net Profit	519	647	775	586	123	154	309	492	338	67	305	303	272	476	518	500	455	677	1,107	-538	781	595	772	28	557	380	996	709	97	1,189	1,114	1,244	960	1,405	1,482	1,381	1,310	1,392	1,342	1,404
EPS in ₹	30.45	37.99	45.42	34.34	7.19	9.06	18.64	29.72	20.38	4.02	18.42	18.25	16.39	28.69	31.22	30.16	27.45	40.81	66.78	-32.48	47.12	35.87	46.54	1.68	33.61	22.95	60.03	42.75	5.84	71.64	67.13	74.91	57.79	84.55	89.09	82.94	78.66	83.61	75.40	16.97

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	18,598	20,384	21,817	22,544	22,466	23,225	26,617	29,747	32,285	38,864
Fixed Assets	5,377	6,563	6,931	6,968	7,191	6,850	8,206	8,122	9,219	10,426
Current Assets	11,877	11,794	9,684	10,498	11,110	12,599	14,550	17,782	20,426	24,805
Capital Work in Progress	529	772	3,325	3,471	2,934	1,535	1,565	1,293	1,030	1,419
Investments	2,102	3,833	2,110	2,298	2,587	2,678	2,212	2,616	4,986	4,931
Other Assets	10,590	9,216	9,452	9,808	9,754	12,162	14,634	17,716	17,050	22,088
Total Liabilities	18,598	20,384	21,817	22,544	22,466	23,225	26,617	29,747	32,285	38,864
Current Liabilities	6,821	6,347	8,420	6,894	5,897	7,214	8,104	9,766	8,572	9,588
Non Current Liabilities	1,923	1,467	1,135	3,079	2,545	412	871	769	427	1,021
Total Equity	9,853	12,570	12,262	12,572	14,024	15,599	17,642	19,212	23,286	28,255
Reserve & Surplus	9,768	12,485	12,179	12,489	13,994	15,616	17,755	19,289	23,330	28,271
Share Capital	85	85	83	83	83	83	83	83	83	83

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-280	-47	-114	-124	-31	-27	1,286	3	-907	133
Investing Activities	-2,370	-1,610	-1,890	-1,483	-769	-495	-2,255	-2,565	-4,109	-4,034
Operating Activities	2,524	3,263	2,144	1,803	2,870	2,984	3,570	2,811	5,888	4,543
Financing Activities	-433	-1,700	-369	-444	-2,133	-2,516	-30	-242	-2,686	-376

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	26.74 %	26.73 %	26.72 %	26.72 %	26.72 %	26.71 %	26.71 %	26.70 %	26.70 %	26.69 %	26.66 %	26.65 %	26.65 %	26.65 %	26.64 %	26.64 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	42.21 %	0.00 %	44.49 %	42.27 %	41.75 %	40.08 %
DIIs	14.25 %	15.08 %	20.92 %	21.95 %	24.46 %	24.95 %	24.47 %	23.38 %	23.05 %	21.99 %	21.04 %	16.21 %	18.31 %	20.73 %	21.48 %	22.90 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	8.31 %	7.76 %	8.14 %	8.27 %	8.37 %	8.22 %	8.06 %	7.84 %	7.59 %	7.51 %	7.91 %	8.44 %	8.25 %	8.07 %	8.07 %	8.07 %
Others	50.70 %	50.43 %	44.22 %	43.07 %	40.45 %	40.12 %	40.76 %	42.08 %	42.66 %	43.80 %	2.18 %	48.69 %	2.30 %	2.29 %	2.06 %	2.30 %
No of Share Holders	2,21,107	2,23,309	2,55,720	2,42,376	2,63,803	2,55,300	2,59,271	2,46,788	2,32,715	2,46,769	2,43,445	2,57,794	2,55,500	2,67,694	3,10,403	4,03,669